Specific sensory detection, discrimination, and hedonic estimation of nicotine enantiomers in smokers and nonsmokers: Are there limitations in replacing the sensory components of nicotine?

Journal of Clinical Psychopharmacology

Volumn 20, Issue 4, 2000, Pages 472-478

  Thuerauf, Norbert ^a,c   Kaegler, Michael ^b   Renner, Bertold ^a   Barocka, Arnd ^a   Kobal, Gerd ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b Inst für Biol Forschung GmbH   (Germany)

^c UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINE DERIVATIVE;

ADULT; ARTICLE; DISCRIMINATIVE STIMULUS; FUNCTIONAL ASSESSMENT; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; SMELLING; SMOKING; STATISTICAL ANALYSIS; TRIGEMINAL NERVE;

ADULT; DISCRIMINATION (PSYCHOLOGY); DOUBLE-BLIND METHOD; HUMANS; MALE; NICOTINE; NICOTINIC AGONISTS; SENSATION; SENSORY THRESHOLDS; SMELL; SMOKING; STEREOISOMERISM; TRIGEMINAL GANGLION;

EID: 0033913146     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004714-200008000-00012     Document Type: Article

References (38)

1. Thuerauf N, Kaegler M, Dietz R, Barocka A, Kobal G. Dose-dependent stereoselective activation of the trigeminal sensory system by nicotine in man. Psychopharmacology (Berl) 1998;142: 236-43.
2. Walker JC, Kendal-Reed M, Keiger CJ, Bencherif M, Silver WS. Olfactory and trigeminal responses to nicotine. Drug Dev Res 1996;38:160-8.
3. Hummel T, Hummel C, Pauli E, Kobal G. Olfactory discrimination of nicotine-enantiomers by smokers and non-smokers. Chem Senses 1992;17:13-21.
4. Hummel T, Livermore A, Hummel C, Kobal G. Chemosensory event-related potentials in man: relation to olfactory and painful sensations elicited by nicotine. Electroencephalogr Clin Neurophysiol 1992;84:192-5.
5. Goldberg SR, Risner ME, Stolerman IP, Reavill C, Garcha HS. Nicotine and some related compounds: effects on schedule-controlled behaviour and discriminative properties in rats. Psychopharmacology (Berl) 1989;97:295-302.
6. Meltzer LT, Rosecrans JA, Aceto MD, Harris LS. Discriminative stimulus properties of the optical isomers of nicotine. Psychopharmacology (Berl) 1980;68:283-6.
7. Henley JM, Oswald RE. Two distinct (-)nicotine binding sites in goldfish brain. Identification and characterization of putative neuronal nicotinic acetylcholine receptor subtypes. J Biol Chem 1987;262:6691-98.
8. Sloan JW, Martin WR, Hernandez J, Hook R. Binding characteristics of (-)-and (+)-nicotine to the rat brain P2 fraction. Pharmacol Biochem Behav 1985;23:987-93.
9. 3H]nicotine to rat brain membranes. Neurochem Res 1985;10:259-67.
10. Martin BR, Aceto MD. Nicotine binding sites and their localization in the central nervous system. Neurosci Biobehav Rev 1981;5: 473-8.
11. Romano C, Goldstein A. Stereospecific nicotine receptors on rat brain membranes. Science 1980;210:647-50.
12. Ikushima S, Muramatsu I, Sakakibara Y, Yokotani K, Fujiwara M. The effects of d-nicotine and 1-isomer on nicotinic receptors. J Pharmacol Exp Ther 1982;222:463-70.
13. Aceto MD, Tucker SM, Ferguson GS, Hinson JR. Rapid and brief tolerance to (+)-and (-)-nicotine in unanesthetized rats. Eur J Pharmacol 1986;132:213-8.
14. Edwards DA, Mather RA, Shirley SG, Dodd GH. Evidence for an olfactory receptor which responds to nicotine-nicotine as an odorant. Experientia 1987;43:868-73.
15. Walker JC, Reynolds JH, Warren DW, Sidman JD. Responses of normal and anosmic subjects to odorants. In: Green BG, Mason JR, Kare MR, eds. Chemical senses. Vol 2: Irritation. New York: Marcel Dekker, 1990:95-117.
16. Thuerauf N, Renner B, Kobal G. Responses recorded from the frog olfactory epithelium after stimulation with R(+)-and S(-)-nicotine. Chem Senses 1995;20:337-44.
17. Kobal G. Pain-related electrical potentials of the human nasal mucosa elicited by chemical stimulation. Pain 1985;22:151-63.
18. Wysocki CJ, Beauchamp GK. Ability to smell androstenone is genetically determined. Proc Natl Acad Sci U S A 1984;81: 4899-902.
19. Drawniek A, Masurat T, Lamm R. Hedonics of odor and odor descriptors. J Air Pollut Control Assoc 1984;34:775-8.
20. Stein C, Mendl G. The German counterpart of McGill pain questionnaire. Pain 1988;32:251-5.
21. Renner B, Meindorfner F, Kaegler M, Thuerauf N, Barocka A, Kobal G. Discrimination of R-and S-nicotine by the trigeminal nerve [abstract]. Chem Senses 1998;23:602.
22. Keiger CJH, Walker JC, Bencherif M, Lippiello PM, Hellmann GM. Messenger RNAs encoding neuronal nicotinic receptor subunits are expressed in the rat olfactory and trigeminal systems [abstract]. Chem Senses 1996;21:621-2.
23. Torebjörk HE, Lamotte RH, Robinson CJ. Peripheral neural correlates of magnitude of cutaneous pain and hyperalgesia: simultaneous recordings in humans of sensory judgments of pain and evoked responses in nociceptors with C-fibers. J Neurophysiol 1984;51:325-39.
24. Shusterman D, Balmes J. Measurement of nasal irritant sensitivity to pulse carbon dioxide: a pilot study. Arch Environ Health 1997;52:334-40.
25. Zeilhofer HU, Kress M, Swandulla D. Fractional Ca2+ currents through capsaicin-and proton-activated ion channels in rat dorsal root ganglion neurones. J Physiol (Lond) 1997;503:67-78.
26. 2+ permeability of the sustained proton-induced cation current in adult rat dorsal root ganglion neurons. J Neurophysiol 1996;76:2834-40.
27. Davies HM, Vaught A. Research cigarettes. Lexington, KY: Tobacco and Health Research Institute, University of Kentucky, 1990:16.
28. Cepeda Benito A. Meta-analytical review of the efficacy of nicotine chewing gum in smoking treatment programs. J Consult Clin Psychol 1993;61:822-30.
29. Tonnesen P, Norregaard J, Mikkelsen K, Jorgensen S, Nilsson F. A double-blind trial of a nicotine inhaler for smoking cessation. JAMA 1993;269:1268-71.
30. American Psychiatric Association. Practice guidelines for the treatment of patients with nicotine dependence. Am J Psychiatry 1996;153[suppl]:1-31.
31. Sutherland G, Stapleton JA, Russell MA, Jarvis MJ, Hajek P, Belcher M, Feyerabend C. Randomised controlled trial of nasal nicotine spray in smoking cessation. Lancet 1992;340:324-9.
32. Silagy C, Mant D, Fowler G, Lodge M. Meta-analysis on efficacy of nicotine replacement therapies in smoking cessation. Lancet 1994;343:139-42.
33. Palmer KJ, Buckley MM, Faulds D. Transdermal nicotine: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy as an aid to smoking cessation. Drugs 1992;44:498-529.
34. Westman EC, Behm FM, Rose JE. Dissociating, the nicotine and airway sensory effects of smoking. Pharmacol Biochem Behav 1996;53:309-15.
35. Behm FM, Schur C, Levin ED, Tashkin DP, Rose JE. Clinical evaluation of a citric acid inhaler for smoking cessation. Drug Alcohol Depend 1993;31:131-8.
36. Levin ED, Behm FM, Carnahan E, LeClair R, Shipley RRJE. Clinical trials using ascorbic acid aerosol to aid smoking cessation. Drug Alcohol Depend 1998;33:211-23.
37. Westman EC, Behm FM, Rose JE. Airway sensory replacement combined with nicotine replacement for smoking cessation: a randomized, placebo-controlled trial using a citric acid inhaler. Chest 1995;107:1358-64.
38. Kornitzer M, Boutsen M, Dramaix M, Thijs J, Gustavsson G. Combined use of nicotine patch and gum in smoking cessation: a placebo-controlled clinical trial. Prev Med 1995;24:41-7.